Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $3,400 | 2 | 80.3% |
| Food and Beverage | $834.29 | 48 | 19.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $3,702 | 17 | $0 (2019) |
| Genentech USA, Inc. | $279.90 | 18 | $0 (2020) |
| Eli Lilly Export S.A. Puerto Rico Branch | $87.69 | 5 | $0 (2020) |
| Lantheus Medical Imaging, Inc. | $81.39 | 6 | $0 (2020) |
| Shire North American Group Inc | $33.49 | 2 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $30.00 | 1 | $0 (2024) |
| Amgen Inc. | $20.17 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $30.00 | 1 | Janssen Pharmaceuticals, Inc ($30.00) |
| 2020 | $81.80 | 6 | Genentech USA, Inc. ($42.71) |
| 2019 | $1,828 | 18 | Merck Sharp & Dohme Corporation ($1,707) |
| 2018 | $2,115 | 13 | Merck Sharp & Dohme Corporation ($1,980) |
| 2017 | $179.59 | 12 | Genentech USA, Inc. ($107.84) |
All Payment Transactions
50 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/23/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/03/2020 | Genentech USA, Inc. | Perjeta (Biological), Kadcyla, TECENTRIQ | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: BioOncology | ||||||
| 08/27/2020 | Lantheus Medical Imaging, Inc. | FLUDEOXYGLUCOSE F-18 (Drug) | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 07/02/2020 | Eli Lilly Export S.A. Puerto Rico Branch | CYRAMZA (Drug), VERZENIO, RETEVMO | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Oncology | ||||||
| 02/10/2020 | Genentech USA, Inc. | Herceptin (Biological), Perjeta, Kadcyla | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: BioOncology | ||||||
| 01/30/2020 | Lantheus Medical Imaging, Inc. | FLUDEOXYGLUCOSE F-18 (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 01/16/2020 | Genentech USA, Inc. | Perjeta (Biological), Kadcyla, TECENTRIQ | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: BioOncology | ||||||
| 12/19/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $14.95 | General |
| 12/05/2019 | Genentech USA, Inc. | Perjeta (Biological), Kadcyla, TECENTRIQ | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: BioOncology | ||||||
| 11/12/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2019 | Eli Lilly Export S.A. Puerto Rico Branch | CYRAMZA (Drug), VERZENIO | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Oncology | ||||||
| 11/01/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: ONCOLOGY | ||||||
| 08/29/2019 | Lantheus Medical Imaging, Inc. | FLUDEOXYGLUCOSE F-18 (Drug) | Food and Beverage | In-kind items and services | $11.06 | General |
| Category: Radiopharmaceutical | ||||||
| 08/01/2019 | Genentech USA, Inc. | Perjeta (Biological), Kadcyla, TECENTRIQ | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: BioOncology | ||||||
| 07/22/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: ONCOLOGY | ||||||
| 06/27/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $14.95 | General |
| 05/06/2019 | Genentech USA, Inc. | Perjeta (Biological), Kadcyla, TECENTRIQ | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: BioOncology | ||||||
| 04/25/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $18.65 | General |
| 04/04/2019 | Genentech USA, Inc. | Perjeta (Biological), TECENTRIQ | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: BioOncology | ||||||
| 03/28/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $11.70 | General |
| 03/22/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $5.01 | General |
| Category: ONCOLOGY | ||||||
| 03/11/2019 | Eli Lilly Export S.A. Puerto Rico Branch | CYRAMZA (Drug), VERZENIO | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Oncology | ||||||
| 01/17/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: ONCOLOGY | ||||||
| 01/10/2019 | Eli Lilly Export S.A. Puerto Rico Branch | CYRAMZA (Drug), VERZENIO | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 109 | 246 | $12,105 | $9,105 |
| 2022 | 4 | 165 | 448 | $21,866 | $16,807 |
| 2021 | 5 | 240 | 672 | $34,664 | $27,008 |
| 2020 | 6 | 284 | 679 | $38,252 | $29,991 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2023 | 12 | 40 | $3,433 | $2,588 | 75.4% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2023 | 18 | 109 | $3,127 | $2,379 | 76.1% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 18 | 19 | $1,853 | $1,372 | 74.0% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 13 | 25 | $1,795 | $1,352 | 75.3% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 25 | 27 | $932.31 | $725.49 | 77.8% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 23 | 26 | $964.50 | $689.45 | 71.5% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2022 | 20 | 111 | $9,451 | $7,471 | 79.0% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2022 | 38 | 205 | $6,069 | $4,549 | 74.9% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2022 | 22 | 22 | $2,199 | $1,650 | 75.0% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2022 | 48 | 51 | $1,837 | $1,371 | 74.6% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 26 | 35 | $1,311 | $973.09 | 74.2% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2022 | 11 | 24 | $998.88 | $792.80 | 79.4% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2021 | 24 | 159 | $15,018 | $11,871 | 79.0% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2021 | 46 | 297 | $8,518 | $6,680 | 78.4% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2021 | 33 | 36 | $3,842 | $2,903 | 75.6% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2021 | 61 | 66 | $2,331 | $1,837 | 78.8% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2021 | 28 | 45 | $1,700 | $1,285 | 75.6% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2021 | 23 | 38 | $1,691 | $1,219 | 72.1% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2021 | 14 | 20 | $1,438 | $1,132 | 78.7% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2021 | 11 | 11 | $126.94 | $83.07 | 65.4% |
| 88341 | Special stained specimen slides to examine tissue | Office | 2020 | 32 | 141 | $13,364 | $10,644 | 79.7% |
| 88341 | Special stained specimen slides to examine tissue | Facility | 2020 | 44 | 269 | $7,979 | $6,377 | 79.9% |
| 88342 | Tissue or cell analysis by immunologic technique | Office | 2020 | 43 | 48 | $5,172 | $4,063 | 78.6% |
| 88360 | Microscopic genetic analysis of tumor | Office | 2020 | 12 | 25 | $3,197 | $2,394 | 74.9% |
| 88342 | Tissue or cell analysis by immunologic technique | Facility | 2020 | 62 | 69 | $2,546 | $2,034 | 79.9% |
About Dr. Luis Ferrer Torres, MD
Dr. Luis Ferrer Torres, MD is a Anatomic Pathology & Clinical Pathology healthcare provider based in Caguas, Puerto Rico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1063473247.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Luis Ferrer Torres, MD has received a total of $4,234 in payments from pharmaceutical and medical device companies, with $30.00 received in 2024. These payments were reported across 50 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($3,400).
As a Medicare-enrolled provider, Ferrer Torres has provided services to 798 Medicare beneficiaries, totaling 2,045 services with total Medicare billing of $82,911. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Anatomic Pathology & Clinical Pathology
- Location Caguas, PR
- Active Since 03/29/2006
- Last Updated 07/03/2013
- Taxonomy Code 207ZP0102X
- Entity Type Individual
- NPI Number 1063473247
Products in Payments
- KEYTRUDA (Biological) $3,615
- Perjeta (Biological) $209.56
- CYRAMZA (Drug) $87.69
- Herceptin (Biological) $70.34
- FLUDEOXYGLUCOSE F-18 (Drug) $36.55
- Quadramet (Drug) $34.05
- XARELTO (Drug) $30.00
- GAMMAGARD (Biological) $20.93
- Neulasta (Biological) $20.17
- GAMMAGARDKIOVIG (Biological) $12.56
- Fludeoxyglucose (Drug) $10.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.